PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway

Brigitte Grouix, Lyne Gagnon(ProMetic Life Sciences (United States))
Journal of Pharmacology and Experimental Therapeutics
August 9, 2018
Cited by 28


Related Papers